Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618
Trial:
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Princess Margaret Hospital

610 University Ave     
Toronto , ON M5G 2M9
Canada

 

Principal Investigator:
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Princess Margaret Hospital Website:
http://www.uhn.ca/index.asp

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.